Cyclosporine Therapy in Type I Diabetes Mellitus
A Role for Cyclosporin A in the Treatment of Insulin‐dependent Diabetes Mellitus? - Nerup - 1985 - Diabetic Medicine - Wiley Online Library
![PDF] Case Study: New-Onset Diabetes After Renal Transplantation | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7596c0acaea0ee52a45e06b595d1183c9e8cf5f2/4-Table1-1.png "PDF] Case Study: New-Onset Diabetes After Renal Transplantation | Semantic Scholar")
PDF] Case Study: New-Onset Diabetes After Renal Transplantation | Semantic Scholar
Understanding the Safety and Efficacy of Cyclosporine Versus Mycophenolate Mofetil in Patients with Renal Failure and Type II Di
Post-transplant Diabetes Mellitus in Kidney Transplant Recipients in Sudan: A Comparison Between Tacrolimus and Cyclosporine-Bas
Side effects of cyclosporine | Download Table
Influencing Factors of New-Onset Diabetes after a Renal Transplant and Their Effects on Complications and Survival Rate | PLOS ONE
Prevention of Type 1 Diabetes - Diabetes in America - NCBI Bookshelf
Untitled
Statins and diabetes risk
HNF4alpha and HNF1alpha Dysfunction as a Molecular Rational for Cyclosporine Induced Posttransplantation Diabetes Mellitus | PLOS ONE
China Cyclosporine / Ciclosporin CAS 79217-60-0 GMP USP/Bp Standard with High Quality Suppliers, Manufacturers, Factory - Made in China - YHLO
Metabolische und immunologische Wirkungen von Cyclosporin bei Diabetesmellitus- Typ-1-Erstmanifestation
PDF) Incidence of Posttransplant Diabetes Mellitus in Kidney Transplant Recipients Immunosuppressed With Sirolimus in Combination With Cyclosporine | Franco Citterio - Academia.edu
PDF) Effects of STZ-induced diabetes and its treatment with vanadyl sulphate on cyclosporine A-induced nephrotoxicity in rats | Tawfeeg Al-Najjar - Academia.edu
Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy: an analysis of two randomized, multicenter trials - heiDOK
IJMS | Free Full-Text | Management of Diabetes Mellitus in Normal Renal Function, Renal Dysfunction and Renal Transplant Recipients, Focusing on Glucagon-Like Peptide-1 Agonist: A Review Based upon Current Evidence
Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy: an analysis of two randomized, multicenter trials | BMC Nephrology | Full Text
One Year Therapy with Cyclosporine A is Useful in Prevention of Early Autoimmune Transformations in Predisposed Patients for T
PDF) The Concentration of Cyclosporine Metabolites Is Significantly Lower in Kidney Transplant Recipients With Diabetes Mellitus | Pal Falck - Academia.edu
The Long-Term Outcomes and Costs of Diabetes Mellitus among Renal Transplant Recipients: Tacrolimus versus Cyclosporine - ScienceDirect
Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy: an analysis of two randomized, multicenter trials | BMC Nephrology | Full Text
Influence of Overt Diabetes Mellitus on Cyclosporine Pharmacokinetics in a Canine Model
